News - Bevacizumab
2012-05-30 10:24:59
MEMPHIS, Tenn., May 30, 2012 /PRNewswire-USNewswire/ -- The West Clinic, the Mid-South's premier cancer center and world-class center of excellence in medical oncology, hematology,
Bayer Submits New Drug Application for Regorafenib for the Treatment of Metastatic Colorectal Cancer
2012-05-23 06:26:15
WAYNE, N.J., May 23, 2012 /PRNewswire/ -- Bayer HealthCare announced today that it has submitted a New Drug Application (NDA) to the U.S.
2012-05-22 00:03:26
VIB researcher Diether Lambrechts, associated with KU Leuven, has discovered a biomarker that might potentially predict which patients will benefit more from treatment with bevacizumab (Avastin).
2012-05-14 02:28:11
INDIANAPOLIS, May 14, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present data from several molecules that make up its clinical oncology pipeline during the 48th Annual Meeting
